Article Text

Download PDFPDF

Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome
  1. R A Maselli1,
  2. J J Ng1,
  3. J A Anderson1,
  4. O Cagney1,
  5. J Arredondo1,
  6. C Williams2,
  7. H B Wessel3,
  8. H Abdel-Hamid3,
  9. R L Wollmann4
  1. 1
    Department of Neurology, University of California Davis, Davis, California, USA
  2. 2
    Department of Neurology, School of Veterinarian Medicine, University of California Davis, Davis, California, 95618, USA
  3. 3
    Department of Pediatrics, Neurology Division, Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA
  4. 4
    Department of Pathology, The University of Chicago, Chicago, Illinois, USA
  1. Dr R A Maselli, Department of Neurology, University of California Davis, Davis, CA, 95618, USA; ramaselli{at}ucdavis.edu

Abstract

Background: We describe a severe form of congenital myasthenic syndrome (CMS) associated with congenital nephrosis and ocular malformations caused by two truncating mutations in the gene encoding the laminin β2 subunit (LAMB2).

Methods and results: Mutational analysis in the affected patient, who has a history of a serious untoward reaction to treatment with acetylcholinesterase inhibition, revealed two frame-shifting heteroallelic mutations, a maternally inherited 1478delG and a paternally inherited 4804delC. An anconeus muscle biopsy demonstrated a profound distortion of the architecture and function of the neuromuscular junction, which was strikingly similar to that seen in mice lacking laminin β2 subunit. The findings included: pronounced reduction of the axon terminal size with encasement of the nerve endings by Schwann cells, severe widening of the primary synaptic cleft and invasion of the synaptic space by the processes of Schwann cells, and moderate simplification of postsynaptic folds and intact expression of the endplate acetylcholinesterase. The endplate potential quantal content was notably reduced, while the frequencies and amplitudes of miniature endplate potentials were only moderately diminished and the decay phases of miniature endplate potentials were normal. Western blot analysis of muscle and kidney tissue and immunohistochemistry of kidney tissue showed no laminin β2 expression.

Conclusion: This case, which represents a new type of synaptic CMS, exemplifies the wide variability of phenotypes associated with LAMB2 mutations and underscores the fundamental role that laminin β2 plays in the development of the human neuromuscular junction.

View Full Text

Statistics from Altmetric.com

Supplementary materials

Footnotes

  • Competing interests: None declared.

  • Funding: This work was supported by the Muscular Dystrophy Association, The Myasthenia Gravis Foundation of America, and The Myasthenia Gravis Foundation of California

  • Patient consent: Obtained

  • ▸ Additional table and figure are published online only at http://jmg.bmj.com/content/vol46/issue3

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.